NCT02528760View on ClinicalTrials.gov

To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

September 24, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Cirrhosis
Interventions
DRUG

Metaclopramide

23\. Metoclopromide to be given 10mg iv 8 hourly

DRUG

Erythromycin

Erythromycin to be given 70mg iv 12 hourly.

OTHER

Placebo

Trial Locations (1)

110070

Institute of liver and Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT02528760 - To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis | Biotech Hunter | Biotech Hunter